A PET scan detects areas of high metabolic activity in the body, which can indicate cancer, infection, or inflammation. If the report shows an infection in the skeleton, it does not necessarily mean your breast cancer has spread to the bones. It could be a separate infection or inflammation in the bones. Further evaluation, such as blood tests, biopsy, or MRI, may be needed to distinguish between infection and cancer involvement. Your oncologist or radiologist will interpret the findings in the context of your overall diagnosis, symptoms, and prior imaging to decide the next steps and treatment plan. Do not jump to conclusions based on PET findings alone.

Elinal 1 mg and Altraz 1 mg both contain anastrozole and are used to prevent breast cancer recurrence. They usually work the same way if the dose and composition are identical. Switching to a more affordable brand is often safe, but medical supervision is important. Consult her doctor before switching so her treatment remains effective and properly monitored.

Breast cancer is diagnosed through a combination of screening and diagnostic tests. Screening often starts with a mammogram, an X-ray of the breast used to detect any unusual changes. If something suspicious is found, doctors may recommend an ultrasound, MRI, or additional imaging to get a clearer view. A definitive diagnosis requires a biopsy, where a small sample of breast tissue is removed and examined under a microscope for cancer cells. Doctors also consider clinical examination, patient history, and sometimes blood tests to evaluate overall health. Early detection through regular screening and timely evaluation of symptoms significantly improves treatment outcomes.

While both Elinal 1 mg and Altraz 1 mg contain the same active ingredient, anastrozole, making them pharmacologically similar, other factors must be considered before switching. These include the drug's release pattern, formulation, inactive ingredients (excipients), stability, and manufacturing quality, which can affect absorption, tolerability, and effectiveness. Do not decide based solely on cost, medical suitability is key. Your mother's oncologist should evaluate these factors along with her age, menopausal status, tumour hormone-receptor profile, bone and liver health, and any other medications before recommending a switch. Always consult the doctor before changing brands or starting treatment.

Stage 4 breast cancer, also called metastatic breast cancer, means the cancer has spread to other parts of the body. Treatment focuses on controlling the disease, relieving symptoms, and improving quality of life, rather than curing it. Options include hormone therapy for hormone-receptor-positive cancers, chemotherapy, targeted therapy for cancers with specific markers (like HER2-positive), and immunotherapy in some instances. Radiation therapy or surgery may be used to relieve symptoms or treat particular areas. The exact plan depends on tumour type, previous treatments, overall health, and patient preferences. It should be determined by a medical oncologist. Regular follow-up and supportive care are essential for managing side effects and maintaining quality of life.

Breast cancer can cause a lump in the breast or underarm, changes in breast size or shape, skin dimpling or redness, nipple discharge or inversion, breast or nipple pain, and swelling in part of the breast, though early cancers may have no noticeable symptoms, making regular screening important. Treatment depends on the type, stage, and hormone-receptor status of the cancer, as well as overall health. It may include surgery, radiation therapy, chemotherapy, hormone therapy (like tamoxifen or aromatase inhibitors), and targeted therapy. The oncologist personalises the treatment plan, and early diagnosis with regular follow-up significantly improves outcomes.